2024-02-012025-03-312025-03-31false15126500Monohill International Ltd2025-09-1946900falseiso4217:GBPxbrli:pure151265002024-01-31151265002025-03-31151265002024-02-012025-03-31151265002023-09-09151265002024-01-31151265002023-09-102024-01-3115126500bus:SmallEntities2024-02-012025-03-3115126500bus:AuditExempt-NoAccountantsReport2024-02-012025-03-3115126500bus:FullAccounts2024-02-012025-03-3115126500bus:PrivateLimitedCompanyLtd2024-02-012025-03-3115126500core:WithinOneYear2025-03-3115126500core:AfterOneYear2025-03-3115126500core:WithinOneYear2024-01-3115126500core:AfterOneYear2024-01-3115126500core:ShareCapital2025-03-3115126500core:SharePremium2025-03-3115126500core:RevaluationReserve2025-03-3115126500core:OtherReservesSubtotal2025-03-3115126500core:RetainedEarningsAccumulatedLosses2025-03-3115126500core:ShareCapital2024-01-3115126500core:SharePremium2024-01-3115126500core:RevaluationReserve2024-01-3115126500core:OtherReservesSubtotal2024-01-3115126500core:RetainedEarningsAccumulatedLosses2024-01-3115126500core:LandBuildings2025-03-3115126500core:PlantMachinery2025-03-3115126500core:Vehicles2025-03-3115126500core:FurnitureFittings2025-03-3115126500core:OfficeEquipment2025-03-3115126500core:NetGoodwill2025-03-3115126500core:IntangibleAssetsOtherThanGoodwill2025-03-3115126500core:ListedExchangeTraded2025-03-3115126500core:UnlistedNon-exchangeTraded2025-03-3115126500core:LandBuildings2024-01-3115126500core:PlantMachinery2024-01-3115126500core:Vehicles2024-01-3115126500core:FurnitureFittings2024-01-3115126500core:OfficeEquipment2024-01-3115126500core:NetGoodwill2024-01-3115126500core:IntangibleAssetsOtherThanGoodwill2024-01-3115126500core:ListedExchangeTraded2024-01-3115126500core:UnlistedNon-exchangeTraded2024-01-3115126500core:LandBuildings2024-02-012025-03-3115126500core:PlantMachinery2024-02-012025-03-3115126500core:Vehicles2024-02-012025-03-3115126500core:FurnitureFittings2024-02-012025-03-3115126500core:OfficeEquipment2024-02-012025-03-3115126500core:NetGoodwill2024-02-012025-03-3115126500core:IntangibleAssetsOtherThanGoodwill2024-02-012025-03-3115126500core:ListedExchangeTraded2024-02-012025-03-3115126500core:UnlistedNon-exchangeTraded2024-02-012025-03-3115126500core:MoreThanFiveYears2024-02-012025-03-3115126500core:Non-currentFinancialInstruments2025-03-3115126500core:Non-currentFinancialInstruments2024-01-3115126500dpl:CostSales2024-02-012025-03-3115126500dpl:DistributionCosts2024-02-012025-03-3115126500core:LandBuildings2024-02-012025-03-3115126500core:PlantMachinery2024-02-012025-03-3115126500core:Vehicles2024-02-012025-03-3115126500core:FurnitureFittings2024-02-012025-03-3115126500core:OfficeEquipment2024-02-012025-03-3115126500dpl:AdministrativeExpenses2024-02-012025-03-3115126500core:NetGoodwill2024-02-012025-03-3115126500core:IntangibleAssetsOtherThanGoodwill2024-02-012025-03-3115126500dpl:GroupUndertakings2024-02-012025-03-3115126500dpl:ParticipatingInterests2024-02-012025-03-3115126500dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-03-3115126500core:ListedExchangeTraded2024-02-012025-03-3115126500dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-03-3115126500core:UnlistedNon-exchangeTraded2024-02-012025-03-3115126500dpl:CostSales2023-09-102024-01-3115126500dpl:DistributionCosts2023-09-102024-01-3115126500core:LandBuildings2023-09-102024-01-3115126500core:PlantMachinery2023-09-102024-01-3115126500core:Vehicles2023-09-102024-01-3115126500core:FurnitureFittings2023-09-102024-01-3115126500core:OfficeEquipment2023-09-102024-01-3115126500dpl:AdministrativeExpenses2023-09-102024-01-3115126500core:NetGoodwill2023-09-102024-01-3115126500core:IntangibleAssetsOtherThanGoodwill2023-09-102024-01-3115126500dpl:GroupUndertakings2023-09-102024-01-3115126500dpl:ParticipatingInterests2023-09-102024-01-3115126500dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-102024-01-3115126500core:ListedExchangeTraded2023-09-102024-01-3115126500dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-102024-01-3115126500core:UnlistedNon-exchangeTraded2023-09-102024-01-3115126500core:NetGoodwill2025-03-3115126500core:IntangibleAssetsOtherThanGoodwill2025-03-3115126500core:LandBuildings2025-03-3115126500core:PlantMachinery2025-03-3115126500core:Vehicles2025-03-3115126500core:FurnitureFittings2025-03-3115126500core:OfficeEquipment2025-03-3115126500core:AfterOneYear2025-03-3115126500core:WithinOneYear2025-03-3115126500core:ListedExchangeTraded2025-03-3115126500core:UnlistedNon-exchangeTraded2025-03-3115126500core:ShareCapital2025-03-3115126500core:SharePremium2025-03-3115126500core:RevaluationReserve2025-03-3115126500core:OtherReservesSubtotal2025-03-3115126500core:RetainedEarningsAccumulatedLosses2025-03-3115126500core:NetGoodwill2024-01-3115126500core:IntangibleAssetsOtherThanGoodwill2024-01-3115126500core:LandBuildings2024-01-3115126500core:PlantMachinery2024-01-3115126500core:Vehicles2024-01-3115126500core:FurnitureFittings2024-01-3115126500core:OfficeEquipment2024-01-3115126500core:AfterOneYear2024-01-3115126500core:WithinOneYear2024-01-3115126500core:ListedExchangeTraded2024-01-3115126500core:UnlistedNon-exchangeTraded2024-01-3115126500core:ShareCapital2024-01-3115126500core:SharePremium2024-01-3115126500core:RevaluationReserve2024-01-3115126500core:OtherReservesSubtotal2024-01-3115126500core:RetainedEarningsAccumulatedLosses2024-01-3115126500core:NetGoodwill2023-09-0915126500core:IntangibleAssetsOtherThanGoodwill2023-09-0915126500core:LandBuildings2023-09-0915126500core:PlantMachinery2023-09-0915126500core:Vehicles2023-09-0915126500core:FurnitureFittings2023-09-0915126500core:OfficeEquipment2023-09-0915126500core:AfterOneYear2023-09-0915126500core:WithinOneYear2023-09-0915126500core:ListedExchangeTraded2023-09-0915126500core:UnlistedNon-exchangeTraded2023-09-0915126500core:ShareCapital2023-09-0915126500core:SharePremium2023-09-0915126500core:RevaluationReserve2023-09-0915126500core:OtherReservesSubtotal2023-09-0915126500core:RetainedEarningsAccumulatedLosses2023-09-0915126500core:AfterOneYear2024-02-012025-03-3115126500core:WithinOneYear2024-02-012025-03-3115126500core:Non-currentFinancialInstrumentscore:CostValuation2024-02-012025-03-3115126500core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-012025-03-3115126500core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-012025-03-3115126500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-012025-03-3115126500core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-012025-03-3115126500core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-012025-03-3115126500core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-012025-03-3115126500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-012025-03-3115126500core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-012025-03-3115126500core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3115126500core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3115126500core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3115126500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3115126500core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3115126500core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3115126500core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3115126500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3115126500core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3115126500core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3115126500core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3115126500core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3115126500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3115126500core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3115126500core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3115126500core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3115126500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3115126500core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3115126500bus:Director12024-02-012025-03-3115126500bus:Director22024-02-012025-03-31

Monohill International Ltd

Registered Number
15126500
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2025

Monohill International Ltd
Company Information
for the period from 1 February 2024 to 31 March 2025

Directors

A P Mahtani
B Saxena

Registered Address

17 Hanover Square
London
W1S 1BN

Registered Number

15126500 (England and Wales)
Monohill International Ltd
Balance Sheet as at
31 March 2025

Notes

31 Mar 2025

31 Jan 2024

£

£

£

£

Current assets
Debtors31,374,66410
Cash at bank and on hand10,102-
1,384,76610
Creditors amounts falling due within one year4(1,386,507)-
Net current assets (liabilities)(1,741)10
Total assets less current liabilities(1,741)10
Net assets(1,741)10
Capital and reserves
Called up share capital1010
Profit and loss account(1,751)-
Shareholders' funds(1,741)10
The financial statements were approved and authorised for issue by the Board of Directors on 19 September 2025, and are signed on its behalf by:
A P Mahtani
Director
Registered Company No. 15126500
Monohill International Ltd
Notes to the Financial Statements
for the period ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with Section 1A of Financial Reporting Standard 102 and Companies Act 2006 as these apply to the financial statements for the period and there were no material departures from the reporting standard.
Going concern
The financial statements have been prepared on a going concern basis notwithstanding the fact that the company has a deficiency on total equity at the end of the year. The director considers this basis to be appropriate as the company has sufficient facilities available from its shareholder to fund its working capital requirement for a period of at least twelve months for the date these financial statements were approved.
Revenue from sale of goods
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: Revenue from the sale of goods is recognised when all of the following conditions are satisfied: • the company has transferred the significant risks and rewards of ownership to the buyer; • the company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; • the amount of revenue can be measured reliably; • it is probable that the company will receive the consideration due under the transaction; and • the costs incurred or to be incurred in respect of the transaction can be measured reliably
Foreign currency translation
Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. At each period end foreign currency monetary items are translated using the closing rate. Nonmonetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined. Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges. Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the profit and loss account within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.
Financial instruments
Financial assets and financial liabilities are recognised when the company becomes party to the contractual provisions of the instrument. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Basic financial assets, including trade and other debtors, and cash and bank balances, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest for a similar debt instrument. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment. Basic financial liabilities, including trade and other creditors, bank loans and loans from fellow group companies, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently carried at amortised cost, using the effective interest method. Financial assets measured at cost and amortised cost are assessed at the end of each reporting period for evidence of impairment. If evidence of impairment is found, an impairment loss is recognised in the profit and loss account. Financial assets are derecognised when (i) the contractual rights to the cashflows from the asset expire or are settled, or (ii) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (iii) despite having retained some significant risks and rewards of ownership, control of the asset has been transferred to another party. Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires. Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.Average number of employees
The average number of employees include directors.

20252024
Average number of employees during the year22
3.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables1,220,331-
Other debtors13,54710
Prepayments and accrued income140,786-
Total1,374,66410
4.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables614,398-
Other creditors742,110-
Accrued liabilities and deferred income29,999-
Total1,386,507-
5.Share capital
10 (2024 - 10) Ordinary shares of £1.00 each